Skip to main content
Clinical Trials/DRKS00030999
DRKS00030999
Not yet recruiting
Not Applicable

Prospective evaluation of non-invasive biomarkers of kidney function and musculoskeletal status with checkpoint inhibitor therapy

niversitätsmedizin Göttingen0 sites200 target enrollmentJanuary 4, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
to prospectively evaluate kidney function and musculoskeletal status in patients receiving a checkpoint inhibitor therapy
Sponsor
niversitätsmedizin Göttingen
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Göttingen

Eligibility Criteria

Inclusion Criteria

  • Malignant disease with indication for checkpoint inhibitor therapy according to current guidelines

Exclusion Criteria

  • Not capable of consent patients
  • Participation in clinical study with blinded use of immune therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials